Save up to £19 when you bundle
An easier way to take weight loss medication
Lose an average of up to 16.6% starting weight*
UK-registered doctors review your request in 24 hours
*OASIS-4, estimated average weight loss of 16.6% if participants remained on Wegovy (oral semaglutide) 25mg for 64 weeks, compared with 2.2% with placebo. Individual results vary.
**based on a survey of over 2,000 ZAVA weight loss patients, reporting results after 3 to 6 months of treatment.
Save up to £19 when you bundle
Spread the cost with PayPal Pay in 3
Every step supported by real doctor guidance
There are currently 2 GLP-1 tablets approved for weight loss in the UK, the Wegovy pill and Foundayo.
Semaglutide
Orforglipron
*OASIS-4, estimated average weight loss of 16.6% if participants remained on Wegovy (oral semaglutide) 25mg for 64 weeks, compared with 2.2% with placebo. Individual results vary.
**ATTAIN-1, estimated average weight loss of 12.4% if participants remained on Foundayo (orforglipron) 17.2mg for 72 weeks, compared with 2.1% with placebo. Individual results vary.
Both the Wegovy pill and Foundayo are daily GLP-1 tablets licensed in the UK for supporting weight loss. They are prescription-only so they need to be approved by a doctor before you can take them. You can request treatment for either online from ZAVA’s online doctor service.
The Wegovy pill is manufactured by Novo Nordisk, the same manufacturer who makes Wegovy injections. This new daily tablet contains semaglutide, the same active ingredient used in the weekly Wegovy injections.
In the Phase 3 OASIS 4 trial, patients lost an average of 16.6% of their starting weight* after 64 weeks at the highest dose of 25mg, and:
*OASIS-4, estimated average weight loss of 16.6% if participants remained on Wegovy (oral semaglutide) 25mg for 64 weeks, compared with 2.2% with placebo. Individual results vary.
The Wegovy tablet is swallowed whole, with a small amount of water if needed. It has to be taken:
These guidelines help make sure the medication is absorbed properly by the body. Food, drink, and other medications can all stop the pill being absorbed and reduce the effectiveness of the treatment.
For more in-depth advice on using the Wegovy pill, see the manufacturer Novo Nordisk’s page.
The side effects of Wegovy pills are similar to the injections. The main difference might be an increased chance of stomach-related side effects due to the pill being absorbed in the digestive system, compared to the injection which is absorbed under the skin.
Very common side effects of Wegovy include:
For a full list of side effects read the Wegovy patient information leaflet.
Foundayo is slightly different from the Wegovy pill in that the active ingredient orforglipron is not already available as approved injection medication.
Unlike semaglutide tablets, orforglipron is a small-molecule GLP-1 medication rather than a peptide-based drug. This means it’s a different kind of medication that can be taken without having to wait before eating, since food and drink won’t stop it being absorbed properly.
In the Phase 3 ATTAIN-1 trial, patients lost an average 12.4% of their starting weight* after 72 weeks on the highest dose of orforglipron – 17.2mg, and:
**ATTAIN-1, estimated average weight loss of 12.4% if participants remained on Foundayo (orforglipron) 17.2mg for 72 weeks, compared with 2.1% with placebo. Individual results vary.
Like the Wegovy pill, Foundayo is swallowed whole with a drink if needed. But, Foundayo offers more flexibility, because unlike the Wegovy pill it can be taken:
These advantages in convenience may make it easier for some people to stick to their treatment long term.
According to the ATTAIN-1 trial, most common side effects included:
Since Foundayo is a GLP-1 medication, it’s likely to cause side effects similar to other GLP-1s like weight loss injections and the Wegovy pill.
The Wegovy pill and Foundayo are both GLP-1 tablets, but there are some key differences between them, as well as similarities.
Both treatments have been shown to be effective for weight loss in clinical trials. The main factors for choosing between them are:
The Wegovy pill has been found to be more effective (16.6% of starting weight lost after 64 weeks on 25mg)* compared to Foundayo (12.4% of starting weight lost after 72 weeks on 36mg).** If you're actively trying to lose weight, our doctors recommend that Wegovy may be the better option for you. Foundayo is a good option for maintaining your goal weight if you’ve already reached it.
Foundayo is generally more convenient to take. With the Wegovy pill, you have to not eat for 8 hours beforehand, taking it when you wake up, then only take it with a small amount of water and wait 30 minutes before eating or drinking anything else. Foundayo only requires you to take it at the same time each day, but this can be any time that suits you, and you can eat and drink with it.
Please note – If you switch to Foundayo from another GLP-1 medication, you may regain some weight. Our doctors recommend staying on your current GLP-1 medication if this is effective for you, rather than switching to Foundayo.
Like GLP-1 injections, GLP-1 tablets are medications that mimic the effects of glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the gut.
They work to:
GLP-1 stands for glucagon-like peptide-1, a hormone released after eating. This hormone sends signals to the brain that help control hunger and appetite. They can be used to support weight loss when used alongside a diet and exercise plan. Because they reduce appetite and increase feelings of fullness, making it easy to eat less and hit the calorie deficit needed for weight loss.
They are taken once daily, which can be easier to remember
Some people find planning their weekly injections a hassle and a daily pill can be less difficult to remember.
They are easier to travel with than GLP-1 injections
You don’t need to worry as much about temperature for tablets compared to injections. This means you don’t need to travel with a cool bag or make sure you have access to a refrigerator at your destination.
They don’t need to be self-injected
Since you just swallow them whole, you don’t need to worry about injecting yourself. Some people don’t feel comfortable with needles or don’t feel confident giving themselves injections.
They are easier to manage and store
You don’t have to worry about refrigeration, replacing needles, or using sharps bins for throwing away needles.
They do not cause injection-site reactions, like bruising or irritation
There is no chance of side effects related to injecting yourself with GLP-1 tablets.
If you’re already aware of how weight loss injections work, then GLP-1 tablets also work in a similar way. They reduce your appetite, making it easier to eat less and hit a calorie deficit for weight loss. The main difference is that, because it’s absorbed through the digestive system and not under the skin, the pill is slightly less effective.
GLP-1 pills contain the same active ingredients as injections, so they work the same way. They help support weight loss by:
The active ingredients in GLP-1 pills belong to a group of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. They work by mimicking the hormone GLP-1, which is responsible for controlling appetite, digestion, and blood sugar.
These pills reduce your appetite and slow down your digestive system. This makes following a diet and exercise plan easier, allowing you to eat fewer calories without feeling as hungry.
Because GLP-1 pills are absorbed after swallowing them, they are not absorbed like the injections, which go directly under the skin. As a result, GLP-1 pills have the same effect as injections, but lead to less average weight loss.
GLP-1 tablets work gradually, just like weight loss injections. Most people notice changes to their appetite before they see significant weight loss. You’ll usually start to notice weight loss over months rather than within the first few weeks.
2%* weight loss
Swipe to view more →
4%* weight loss
← Swipe to view more →
5 to 6%* weight loss
← Swipe to view more →
7 to 8%* weight loss
← Swipe to view more →
10%* weight loss
← Swipe to view more →
12.4 to 16.6%* weight loss
← Swipe to view previous
*OASIS-4, estimated average weight loss of 16.6% if participants remained on Wegovy (oral semaglutide) 25mg for 64 weeks, compared with 2.2% with placebo & ATTAIN-1, estimated average weight loss of 12.4% if participants remained on Foundayo (orforglipron) 17.2mg for 72 weeks, compared with 2.1% with placebo. Individual results vary.
Remember that everyone’s weight loss journey is different and it may take time before you notice significant weight loss.
Month 1
Estimated 2% average weight loss.*
This is the early phase. You will have just started treatment and hopes will be high. You may notice right away that you feel less hungry, which can be encouraging. However, it’s important to remember that it won’t translate into noticeable weight loss right away, and you could get some side effects. Don’t let any setbacks get you down and stick to your plan.
You may notice:
Some people may lose a small amount of weight during this period, but again, this is not guaranteed.
Month 2
Estimated 4% average weight loss.*
By this point you should be comfortably settled into your new lifestyle. You’ll be used to your new appetite and how to manage eating less, but still having a balanced diet. You should also be keeping up your exercise routine.
The great news is that by now you should have seen noticeable weight loss, which can be very encouraging. Once you make it to this stage, you’ll be able to see your treatment is making a difference, and that can help you stay motivated to keep at it.
You may begin to notice:
You may continue to increase your dose gradually during this period, taking into account whether you feel you need a stronger dose and if you’ve had any difficult side effects.
Months 3 to 6
Estimated 5 to 10% average weight loss.*
By this point you should be comfortably settled into your new lifestyle. You’ll be used to your new appetite and how to manage eating less, but still having a balanced diet. You should also be keeping up your exercise routine.
The great news is that by now you should have seen noticeable weight loss, which can be very encouraging. Once you make it to this stage, you’ll be able to see your treatment is making a difference, and that can help you stay motivated to keep at it.
You may begin to notice:
You may continue to increase your dose gradually during this period, taking into account whether you feel you need a stronger dose and if you’ve had any difficult side effects.
Beyond 6 months
Estimated 12.4 to 16.6% average weight loss.*
Remember that weight loss treatment is a long term commitment and the full benefits take years to see, not weeks. Still, in 64 to 72 weeks, you could be reaching the goal weight you’re looking forward to right now.
By now you could be:
*OASIS-4, estimated average weight loss of 16.6% if participants remained on Wegovy (oral semaglutide) 25mg for 64 weeks, compared with 2.2% with placebo & ATTAIN-1, estimated average weight loss of 12.4% if participants remained on Foundayo (orforglipron) 17.2mg for 72 weeks, compared with 2.1% with placebo. Individual results vary.
If you meet the body mass index (BMI) requirements for GLP-1 treatment, tablets could be a good choice for you. As long as you meet the criteria and there are no safety reasons why you cannot use GLP-1 tablets, they should be right for you.
A doctor can check if the GLP-1 tablets are a suitable treatment for you. Our consultation service includes a doctor assessment and BMI verification.
GLP-1 tablets are only meant as a weight loss treatment for people who are obese, or overweight with certain other risk factors. We can only safely and legally prescribe them online if we check to make sure people meet the prescribing criteria.
This includes checking that people are the BMI they say they are. As well as asking people to tell us their BMI during their treatment consultation, we also ask them to take pictures so we can confirm their BMI and prescribe treatment safely.
For more information about how we verify BMI, see the section on ‘how our service works’. If you need to check your BMI before ordering treatment, use our free online BMI calculator.
GLP-1 tablets may not be right for you if you:
You should also speak to your doctor before starting GLP-1 tablets if you:
You may not be able to use Wegovy pill or may require doctor supervision if you are also taking:
You may not be able to use Foundayo or may require doctor supervision if you are also taking:
If you have a chance of getting pregnant and are sexually active, you must use contraception while taking GLP-1 tablets, as the effects of their active ingredients on an unborn baby has not been tested. If you get side effects that stop your oral contraceptive pill from being effective, or you miss a pill, use condoms and speak to your doctor or a sexual health clinic about the coil or implant.
If you want convenient and discreet support on your weight loss journey, ZAVA’s service allows you to be assessed for weight loss treatment remotely. If a doctor approves treatment, it can then be posted to you.
Complete a short medical questionnaire online, take photos, and confirm your ID.
One of our doctors will review your request, usually within a few hours, to check whether treatment is suitable.
If approved, your treatment is dispatched with tracked next-day delivery in discreet packaging.
Requesting weight loss treatment from ZAVA is simple:
Clinically proven treatments
Treatments that help reduce appetite, food noise and cravings.
Doctors who check in
Regular check-ins and messages for guidance when you need it.
Support beyond the medication
Guidance to help manage appetite, routines and consistency.
What you see is what you pay
No subscription, no hidden fees and no unexpected costs.
At ZAVA, we offer a comprehensive weight loss service that includes effective treatments, ongoing care and support, free weight loss guides and other materials, regular check-ins, and a weight loss maintenance service to help you keep the weight off once you reach your goal weight.
feel better*
|
feel more confident*
|
have more energy*
|
*based on a survey of over 2,000 ZAVA weight loss patients, reporting results after 3 to 6 months of treatment.
We’ve helped 100,000s of patients lose weight through our treatment service. Our patients rate our online doctor service as ‘excellent’ on Trustpilot. Feel free to check out some example reviews from our patients.
| GLP-1 pills | GLP-1 injections | |
|---|---|---|
| Effectiveness | Up to 16.6%* estimated average starting weight loss | Up to 22.5% average starting weight loss** |
| How they’re taken | Swallowed whole | Self-injected under the skin |
| When they are taken | Daily | Weekly |
| Do they require cold storage? | No | Yes |
| Do they require reusing devices or throwing away needles? | No | Yes |
| Are they easy to travel with? | Yes | No |
| Do they have a higher risk of stomach-related side effects? | Yes | No |
| Do they have a risk of injection site side effects | No | Yes |
*OASIS-4, estimated average weight loss of 16.6% if participants remained on Wegovy (oral semaglutide) 25mg for 64 weeks, compared with 2.2% with placebo. Individual results vary.
**SURMOUNT-1, estimated average weight loss of 22.5% if participants remained on Mounjaro (tirzepatide) 15mg for 72 weeks, compared with 3.1% with placebo. Individual results vary.
➤ For a more detailed look at comparing GLP-1 pills and injections, see our GLP-1 injections vs pills page.
For active weight loss, injections are the most effective treatments available. However, if you don’t feel comfortable self-injecting, or you find a daily pill easier to manage, you could try GLP-1 pills instead. The Wegovy pill is the better choice for active weight loss and Foundayo is better suited to maintaining your goal weight.
Yes, it is possible. As long as it’s still safe for you to take your injections, you should be able to switch to a GLP-1 pill with a doctor’s approval. Depending on the dose of your current treatment, you may be able to switch to a dose higher than the starting dose of either GLP-1 pill. If you switch to Foundayo from a GLP-1 injection, you may regain some weight.
For more information see:
GLP-1 tablets are more effective overall. Existing oral weight loss treatments include fat-binding capsules that contain orlistat and Mysimba, which also lowers appetite.
| Wegovy pill | Foundayo | Orlistat | Mysimba | |
|---|---|---|---|---|
| Active ingredient(s) | Semaglutide | Orforglipron | Orlistat | Naltrexone and bupropion |
| How they work | Lowers appetite | Lowers appetite | Stops fat being absorbed from food | Lowers appetite |
| Average starting weight loss | 16.6%* after 64 weeks on 25mg | 12.4%** after 72 weeks on 36mg | 10.2%*** after 52 weeks on 120mg | 8.1%**** after 56 weeks on 8mg/90mg |
| % of people losing at least 5% starting weight | 79.2%* after 64 weeks on 25mg | 71.8%** after 72 weeks on 36mg | - | 48%**** after 56 weeks on 8mg/90mg |
| Availability | Prescription only | Prescription only | Over the counter options available | Prescription only |
*OASIS-4, estimated average weight loss of 16.6% if participants remained on Wegovy (oral semaglutide) 25mg for 64 weeks, compared with 2.2% with placebo. Individual results vary.
**ATTAIN-1, estimated average weight loss of 12.4% if participants remained on Foundayo (orforglipron) 17.2mg for 72 weeks, compared with 2.1% with placebo. Individual results vary.
***European Multicenter Orlistat Study, average weight loss of 10.2% during the first year with orlistat 120mg, compared with 6.1% with placebo. Individual results vary.
****COR-1, average weight loss of 8.1% after 56 weeks among participants who completed the study while taking Mysimba (naltrexone/bupropion) 8mg/90mg, compared with 1.3% with placebo. Individual results vary.
As long as a doctor agrees, you can try out any weight loss pill. However, the Wegovy pill is the most effective weight loss pill available in the UK. You can also get low-dose orlistat over the counter as alli or Orlos, but remember that you can request a range of prescription weight loss pills from ZAVA online.
The Wegovy pill does come with some restrictions around how you take it, requiring 8 hours of no food and water before you take it, taking it with a small amount of water (120ml), and then waiting 30 minutes before any other food and drink. Orlistat also has to be taken before every meal that contains fat and Mysimba can be taken up to twice daily, depending on the dose. Foundayo is the simplest to take – once daily, at the same time each day, whatever time suits you best. However, Foundayo is not as effective as Wegovy for active weight loss and is better for when you’ve reached your goal weight.
Many people notice appetite changes within the first few weeks. However, it may be months before you see significant weight loss, as it takes time for changes to diet and lifestyle to take effect.
It is possible to stay on GLP-1 pills for years. Studies on GLP-1 weight loss treatments usually last over 1 year and that’s when they are proven to be effective. As long as it’s safe for you to keep taking them, doctors can approve you staying on GLP-1 medication for a number of years to reach and maintain your goal weight.
No. Currently, neither the Wegovy pill nor Foundayo are available on the NHS. While both have been approved for weight loss in the UK, the NHS has not yet begun to offer weight loss treatment with either pill yet.
No. There is no Mounjaro pill available and there is unlikely to ever be a pill with the active ingredient in Mounjaro (tirzepatide) available for weight loss. This is because tirzepatide breaks down too quickly in the stomach for it to be absorbed properly in the body, which means it wouldn’t have any effect.
Accreditations: MB, ChB, MPH
Dr Kathryn Basford is a GP based in London. She graduated from the University of Manchester and completed her GP training through Whipps Cross Hospital in London. Outside of work she enjoys baking and keeping active, running marathons, swimming, and triathlons.
Last reviewed: 01 Sept 2026
Wegovy 25 mg tablets, emc [accessed 21 August 2026]
Foundayo 17.2mg, emc [accessed 21 August 2026]
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity, The New England Journal of Medicine [accessed 21 August 2026]
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment, The New England Journal of Medicine [accessed 21 August 2026]
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group, The Lancet [accessed 21 August 2026]
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial, The Lancet [accessed 21 August 2026]
Tirzepatide Once Weekly for the Treatment of Obesity, The New England Journal of Medicine [accessed 21 August 2026]
Our doctors are regulated by the CQC and GPhC, the same bodies overseeing NHS care.
Medical Director
Clinical Lead for Service Expansion
Online Doctor